First Time Loading...

Iovance Biotherapeutics Inc
NASDAQ:IOVA

Watchlist Manager
Iovance Biotherapeutics Inc Logo
Iovance Biotherapeutics Inc
NASDAQ:IOVA
Watchlist
Price: 11.64 USD 0.87% Market Closed
Updated: Apr 28, 2024
Section:
 

Wall Street
Price Targets

IOVA Price Targets Summary
Iovance Biotherapeutics Inc

Wall Street analysts forecast IOVA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IOVA is 26.52 USD with a low forecast of 19.19 USD and a high forecast of 35.7 USD.

IOVA Lowest Forecast
Wall Street Target
19.19 USD
65% Upside
IOVA Average Forecast
Wall Street Target
26.52 USD
128% Upside
IOVA Highest Forecast
Wall Street Target
35.7 USD
207% Upside
Lowest
Price Target
19.19 USD
65% Upside
Average
Price Target
26.52 USD
128% Upside
Highest
Price Target
35.7 USD
207% Upside

IOVA Last Price Targets
Iovance Biotherapeutics Inc

The latest public price target was made on Mar 14, 2024 by Joseph Catanzaro from Piper Sandler , who expects IOVA stock to rise by 63% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Joseph Catanzaro
Piper Sandler
19 USD
Upside 63%
1 month ago
Mar 14, 2024
Iovanace Biotherapeutics (IOVA) PT Raised to $19 at Piper Sandler
StreetInsider
Joseph Catanzaro
Piper Sandler
Price Target 19 USD
Upside/Downside 63%
View Source
Iovance Biotherapeutics Inc Competitors:
Price Targets
G
144510
GC Cell Corp
97% Upside
300406
Beijing Strong Biotechnologies Inc
24% Upside
9969
InnoCare Pharma Ltd
60% Upside
LEGN
Legend Biotech Corp
94% Upside
G
144510
GC Cell Corp
97% Upside
300406
Beijing Strong Biotechnologies Inc
24% Upside
9969
InnoCare Pharma Ltd
60% Upside
LEGN
Legend Biotech Corp
94% Upside
300685
Amoy Diagnostics Co Ltd
41% Upside
6160
Beigene Ltd
50% Upside
SOBI
Swedish Orphan Biovitrum AB (publ)
21% Upside
ORY
Oryzon Genomics SA
227% Upside

Revenue
Forecast

Revenue Estimate
Iovance Biotherapeutics Inc

The compound annual growth rate of Iovance Biotherapeutics Inc's revenue for the next 3 years is 724%.

N/A
Past Growth
724%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Iovance Biotherapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Iovance Biotherapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-54%
Average Miss
What are analyst estimates?

See Also

Summary
IOVA intrinsic value, competitors valuation, and company profile.
DCF Valuation
IOVA stock valuation using Discount Cash Flow valuation method.
Relative Valuation
IOVA stock valuation using valuation multiples.
Wall Street Estimates
IOVA price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
IOVA stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is IOVA's stock price target?
Price Target
26.52 USD

According to Wall Street analysts, the average 1-year price target for IOVA is 26.52 USD with a low forecast of 19.19 USD and a high forecast of 35.7 USD.

What is Iovance Biotherapeutics Inc's Revenue forecast?
Projected CAGR
724%

The compound annual growth rate of Iovance Biotherapeutics Inc's revenue for the next 3 years is 724%.

ALPHA SPREAD
Join more than 132,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.